alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
June 16, 2015

Mr. John Swasey

President

Exec Air

160 13th Street, NW.

Naples, FL 34120

Dear Mr. Swasey:

This is in response to your December 31, 2014 letter (public docket No. FAA-2015-0011) 

submitted on behalf of Exec Air and your January 26, 2015 letter (public Docket No. FAA2015-0166) petitioning the Federal Aviation Administration to amend § 135.243(a)(1) of 

Title 14, Code of Federal Regulations (14 CFR). Because the two petitions were submitted 

from the same individual and for the same CFR, the two dockets were combined into one 

docket, Docket No. FAA-2015-0011.

The FAA has considered your request. However, when the FAA responds to petitions for 

rulemaking, it must follow the requirements of 14 CFR Part 11, particularly those guidelines 

for processing petitions for rulemaking found in § 11.73. As stated in that section, the FAA 

uses the following criteria when making a decision as to whether or not to amend current 

regulations based on a petition for rulemaking: 

1) the immediacy of the safety or security concerns the petition raises;

2) the priority of other FAA issues; and

3) the resources we have available to address these issues.

That petition for rulemaking seeks to amend § 135.243(a)(1) to only require a commercial 

pilot certificate to operate a light or midsized piston twin aircraft weighing less than 12,500 

lbs. maximum takeoff weight in a part 135 (nine passenger seats or less) commuter operation.

The FAA has a priority list for rulemaking that addresses many issues that are critical to the

safety of the aviation community and the traveling public. The FAA must prioritize its 

limited rulemaking resources to deliver the most value to the aviation system as a whole. 

Although the issues raised in your petition may have merit, they do not address an immediate 

safety concern.
2

In addition, in your January 26, 2015 correspondence, we note that you petitioned for an 

exemption if rulemaking was not possible. The FAA has determined that this request could 

not be processed as an exemption because it does not meet § 11.81. Guidelines for 

submitting a petition for exemption are available at: 

http://www.faa.gov/regulations_policies/rulemaking/ 

For the reasons stated above, we are unable to process your requests and thereby deny your 

petition for rulemaking in accordance with 14 CFR § 11.73. Although the FAA has decided to 

deny the requests, your comments and reasons for a rule change will be considered if the 

agency undertakes future rulemaking in this area. Accordingly, Docket No. FAA-2015-0011

is being closed.

Sincerely,

/s/

John Barbagallo

Deputy Director, Flight Standards Service
3

Project No.: AFS-13-202-E

Project Officer: _______________

ARM-101:KJones:3/11/2013:Doc# 43636

ARM-1/100/104:Program Office AFS-800
Editorial Note on Part 1315
Editorial Note: Nomenclature changes to part appear at 82 FR 97041, Dec. 30, 2016.

§ 1315.03 Personal use exemption. A person need not register as an importer, file an import declaration, and obtain an import quota if both of the following conditions are met: ( a ) The person purchases scheduled listed chemical products at retail and imports them for personal use, by means of shipping through any private or commercial carrier or the Postal Service.
( b ) In any 30-day period, the person imports no more than 7.5 grams of ephedrine base, 7.5 grams of pseudoephedrine base, and 7.5 grams of phenylpropanolamine base in scheduled listed chemical products.
# m8885.docx

EUROPEAN COMMISSION Brussels, 16.05.2018 C(2018) 3125 final To the notifying party Subject : Case M. 8885 – CARLYLE / ACCOLADE WINES HOLDINGS AUSTRALIA / ACCOLADE WINES HOLDINGS EUROPE Commission decision pursuant to Article 6(1 )( b) of Council Regulation (EC) No 139/2004 1 and Article 57 of the Agreement on the European Economic Area 2 Dear Sir or Madam, 1. On 13 April 2018 , the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which Carlyle Asia Partners IV, L.P., belonging to the the Carlyle Group (United States) indirectly acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Accolade Wines Holdings Australia Pty Ltd (Australia) and Accolade Wines Holdings Europe Limited (United Kingdom) (together the 'Accolade Group'), both controlled by funds managed by CHAMP III Management Pty Ltd , by way o f purchase of shares . 3 2. The business activities of the undertakings concerned are: - for the Carlyle Group : global alternative asset management, - for the Accolade Group : production, marketing and sale predominantly at wholesale level of wine and wine products . 3. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5 ( b ) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 . 4 4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1 )( b) of the Merger Regulation and Article 57 of the EEA Agreement . For the Commission ( S igned )
Johannes LAITENBERGER Director - General
(1)
OJ L 24, 29.1.2004, p. 1 ( the ' Merger Regulation ' ). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ( ' TFEU ' ) has introduced certain changes, such as the replacement of ' Community ' by ' Union ' and ' common market ' by ' internal market ' . The terminology of the TFEU will be used throughout this decision.
(2) OJ L 1, 3.1.1994, p. 3 ( the ' EEA Agreement ' ).
(3) Publication in the Official Journal of the European Union No C 143 , 24 . 4 . 2018 , p. 8 .
(4)
OJ C 366, 14.12.2013, p. 5 .
§ 186.1256 Clay (kaolin). ( a ) Clay (kaolin) Al2O3.2SiO2.nH2O, Cas Reg. No. 1332-58-7) consists of hydrated aluminum silicate. The commercial products of clay (kaolin) contain varying quantities of alkalies and alkaline earths. Clay (kaolin) is a white to yellowish or grayish fine powder. There are at least three different minerals, kaolinite, dickite, and nacrite, classified as kaolin. Kaolinite or china clay is whiter, less contaminated with extraneous minerals, and less plastic in water.
( b ) In accordance with § 186.1(b)(1), the ingredient is used as an indirect human food ingredient with no limitation other than current good manufacturing practice. The affirmation of this ingredient as generally recognized as safe (GRAS) as an indirect human food ingredient is based upon the following current good manufacturing practice conditions of use: ( 1 ) The ingredient is used in the manufacture of paper and paperboard that contact food.
( 2 ) The ingredient is used at levels not to exceed current good manufacturing practice.
( c ) Prior sanctions for this ingredient different from the uses established in this regulation do not exist or have been waived.
[47 FR 43367, Oct. 1, 1982]
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 12-6272

UNITED STATES OF AMERICA,

 Plaintiff – Appellee,

v.

HASSAN GENELL HINES,

 Defendant - Appellant.

Appeal from the United States District Court for the Eastern 

District of North Carolina, at Raleigh. Terrence W. Boyle, 

District Judge. (5:07-cr-00323-BO-1; 5:11-cv-00337-BO)

Submitted: April 26, 2012 Decided: May 1, 2012

Before GREGORY, AGEE, and WYNN, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Hassan Genell Hines, Appellant Pro Se. Jennifer P. May-Parker, 

Assistant United States Attorney, Raleigh, North Carolina, for 

Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Hassan Genell Hines seeks to appeal the district 

court’s orders denying his 28 U.S.C.A. § 2255 (West Supp. 2011) 

motion and denying reconsideration. The orders are not 

appealable unless a circuit justice or judge issues a 

certificate of appealability. 28 U.S.C. § 2253(c)(1)(B) (2006). 

A certificate of appealability will not issue absent “a 

substantial showing of the denial of a constitutional right.” 

28 U.S.C. § 2253(c)(2) (2006). When the district court denies 

relief on the merits, a prisoner satisfies this standard by 

demonstrating that reasonable jurists would find that the 

district court’s assessment of the constitutional claims is 

debatable or wrong. Slack v. McDaniel, 529 U.S. 473, 484 

(2000); see Miller-El v. Cockrell, 537 U.S. 322, 336-38 (2003). 

When the district court denies relief on procedural grounds, the 

prisoner must demonstrate both that the dispositive procedural 

ruling is debatable, and that the motion states a debatable 

claim of the denial of a constitutional right. Slack, 529 U.S. 

at 484-85. 

We have independently reviewed the record and conclude 

that Hines has not made the requisite showing. Accordingly, we 

deny a certificate of appealability and dismiss the appeal. We 

dispense with oral argument because the facts and legal 
3

contentions are adequately presented in the materials before the 

court and argument would not aid the decisional process.

DISMISSED
Editorial Note on Part 177
Editorial Note: Nomenclature changes to part 177 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 177.2500 Polyphenylene sulfone resins. The polyphenylene sulfone resins (CAS Reg. No. 31833-61-1) identified in paragraph (a) of this section may be safely used as articles or components of articles intended for repeated use in contact with food, subject to the provisions of this section. ( a ) *Identity.* For the purpose of this section, polyphenylene sulfone resins consist of basic resin produced by reacting polyphenylene sulfide with peracetic acid such that the finished resins meet the specifications set forth in paragraph (c) of this section. The polyphenylene sulfide used to manufacture polyphenylene sulfone is prepared by the reaction of sodium sulfide and *p*-dichlorobenzene, and has a minimum weight average molecular weight of 5,000 Daltons.
( b ) *Optional adjuvant substances.* The basic polyphenylene sulfone resins identified in paragraph (a) of this section may contain optional adjuvant substances required in the production of such basic resins. These optional adjuvant substances may include substances permitted for such use by regulations in parts 170 through 189 of this chapter, substances generally recognized as safe in food, or substances used in accordance with a prior sanction or approval.
( c ) *Specifications.* The glass transition temperature of the polymer is 360±5 °C as determined by the use of differential scanning calorimetry.
[65 FR 15058, Mar. 21, 2000]
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 (18 U.S.C. 1350)

The undersigned, Stephen I. Sadove, Chief Executive Officer of Saks Incorporated (the Company), has executed this
certification in connection with the filing with the Securities and Exchange Commission of the Companys Quarterly Report on Form 10-Q for the quarter ended August 4, 2007 (the Report).

The undersigned hereby certifies that:



| | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------

IN WITNESS WHEREOF, the undersigned has executed this certification as of the 7th day of September, 2007.



|                                         
|-----------------------------------------
|                                         
|/s/ Stephen I. Sadove                    
|Stephen I. Sadove Chief Executive
Officer

A signed original of this written statement required by Section 906 has been provided to Saks Incorporated
and will be retained by Saks Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.
<Page>

                                 CERTIFICATIONS

                                                                    EXHIBIT 31.1

I, Casey J. Sylla, certify that:

1. I have reviewed this report on Form 10-K of Glenbrook Life and Annuity
Company;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

c) Disclosed in this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.

Date: March 24, 2004

                                                /s/ Casey J. Sylla
                                                ------------------
                                                Casey J. Sylla
                                                President and
                                                Chief Executive Officer
[Federal Register Volume 75, Number 36 (Wednesday, February 24, 2010)]
[Notices]
[Page 8373]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-3739]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Human Genome Research Institute 
Special Emphasis Panel, GWAS Comparing Design Approaches for 
Sequencing Disease.
    Date: March 11, 2010.
    Time: 12 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, NHGRI Twinbrook Library, 
5635 Fishers Lane, Bethesda, MD 20892-9306.
    Contact Person: Keith McKenney, PhD, Scientific Review Officer, 
NHGRI, 5635 Fishers Lane, Suite 4076, Bethesda, MD 20814, 301-594-
4280, <a href="/cdn-cgi/l/email-protection#cea3ada5aba0a0abb7a58ea3afa7a2e0a0a7a6e0a9a1b8"><span class="__cf_email__" data-cfemail="7a1719111f14141f03113a171b131654141312541d150c">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

    Dated: February 17, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-3739 Filed 2-23-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Dear Sir; I support the Medical Exemption DocketNumberFAA-2012-0350.

I am a 55 year old CFI, and have been a pilot for 39 years. My flight hours total S<nf?

### Ijf]Y!a~C~ssna)J7:}: with !50horsepower 25 hours peryear. The airport I fly out ofis Bult Field, a privately owned non-tower airport , locatedjust south ofChicago, II. Before I fly, I always check how I feel physically for the upcoming flight. The education course included in this exemption would help me evaluate ifI am fit to fly. My family owned a general aviation facility, which went by the name ofSangerAirport, for 58 years. We sold itto an individual who I taught how to fly. He expanded to more than double in size from when we owned it. Allowing this option that reduces the burden ofthe 3rd_ Class medical certificate for pilots who fly recreationally, would help increase the number ofpilots flying at this airport. I know many pilots who sold their airplanes, when trying to obtain a 3rd. Class physical became too burdensome. I successfully completedthe FAA Aviation Learning Center Online Course, Navigating The D.C. ADIZ/ SFRA and TFRs and SPECIAL USE AIRSPACE. A valuable benefit ofthese courses are theE-mails I get from the FAA for T.F.R.s, when president Obama is in the area. These happen frequently in the Chicago area. Sincerely Yours, 

# V.

__.**~**

# ~n~~~ 1627 Markey Lane Flossmoor, II. 60422-1933 E-mail : sangerair@att.net June 19,2012
EXHIBIT  99.2


                Certification Pursuant to 18 U.S.C. Section 1350,
                    As Adopted Pursuant to Section 906 of the
                          Sarbanes - Oxley Act of 2002

In  connection  with  the  Quarterly  Report  of  Semele  Group Inc., a Delaware
corporation  (the "Company"), on Form 10-Q for the period ended June 30, 2002 as
filed  with  the  Securities  and  Exchange  Commission  on the date hereof (the
"Report"),  the  undersigned, the Chief Financial Officer of the Company, hereby
certifies  pursuant to 18 U.S.C.  1350 as adopted pursuant to Section 906 of the
Sarbanes-Oxley  Act  of  2002  that:

(1)     the  Report  of  the  Partnership  filed  today  fully complies with the
requirements  of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934;
and

(2)     the information contained in the Report fairly presents, in all material
respects,  the  financial  condition  and  results of operations of the Company.

                    /s/  Richard  K.  Brock
                    -----------------------
                    Richard  K.  Brock
                    Chief  Financial  Officer
                    November  26,  2002
§ 2.35 Use of secondhand containers for the shipment or storage of food and animal feed. ( a ) Investigations by the Food and Drug Administration, the National Communicable Disease Center of the U.S. Public Health Service, the Consumer and Marketing Service of the U.S. Department of Agriculture, and by various State public health agencies have revealed practices whereby food and animal feed stored or shipped in secondhand containers have been rendered dangerous to health. Such contamination has been the result of the original use of these containers for the storage and shipment of articles containing or bearing disease organisms or poisonous or deleterious substances.
( b ) The Commissioner concludes that such dangerous or potentially dangerous practices include, but are not limited to, the following: ( 1 ) Some vegetable growers and packers employ used poultry crates for shipment of fresh vegetables, including cabbage and celery. Salmonella organisms are commonly present on dressed poultry and in excreta and fluid exudates from dressed birds. Thus wooden crates in which dressed poultry has been iced and packed are potential sources of Salmonella or other enteropathogenic microorganisms that may contaminate fresh vegetables which are frequently consumed without heat treatment.
( 2 ) Some potato growers and producers of animal feeds use secondhand bags for shipment of these articles. Such bags may have originally been used for shipping or storing pesticide-treated seed or other articles bearing or containing poisonous substances. Thus these secondhand bags are potential sources of contamination of the food or animal feed stored or shipped therein.
( c ) In a policy statement issued April 11, 1968, the Food and Drug Administration declared adulterated within the meaning of section 402(a) of the Federal Food, Drug, and Cosmetic Act shipments of vegetables or other edible food in used crates or containers that may render the contents injurious to health. This policy statement is extended so that the Food and Drug Administration will regard as adulterated within the meaning of section 402(a) of the act shipments of vegetables, other edible food, or animal feed in used crates, bags, or other containers that may render the contents injurious to health.